Trials / Completed
CompletedNCT00772291
Chronic Pain Management After Herniorraphy
Chronic Pain Management After Herniorraphy:Pregabalin vs Placebo. A Double-blinded Randomised Controlled Clinical Trial.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Erasmus Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Nowadays, chronic pain mainly as a result of iatrogenic nerve damage is generally considered as the most frequent complication after inguinal hernia surgery. The primary objective of this randomised double-blind placebo-controlled trial is to investigate whether pregabalin reduces pain in patients with chronic pain of neuropathic origin after herniorraphy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin | pregabalin 150-600mg/day during 8 weeks |
| DRUG | placebo | placebo drug during 8 weeks |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2010-08-01
- Completion
- 2010-10-01
- First posted
- 2008-10-15
- Last updated
- 2011-08-19
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00772291. Inclusion in this directory is not an endorsement.